AU2001226922A1 - Cancer associated genes and their products - Google Patents

Cancer associated genes and their products

Info

Publication number
AU2001226922A1
AU2001226922A1 AU2001226922A AU2692201A AU2001226922A1 AU 2001226922 A1 AU2001226922 A1 AU 2001226922A1 AU 2001226922 A AU2001226922 A AU 2001226922A AU 2692201 A AU2692201 A AU 2692201A AU 2001226922 A1 AU2001226922 A1 AU 2001226922A1
Authority
AU
Australia
Prior art keywords
products
cancer associated
associated genes
genes
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001226922A
Inventor
Geng Li
Shahid Mian
Robert Charles Rees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nottingham Trent University
Original Assignee
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nottingham Trent University filed Critical Nottingham Trent University
Publication of AU2001226922A1 publication Critical patent/AU2001226922A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001226922A 2000-01-18 2001-01-18 Cancer associated genes and their products Abandoned AU2001226922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0000993.6A GB0000993D0 (en) 2000-01-18 2000-01-18 Cancer associated genes and their products
GB0000993 2000-01-18
PCT/GB2001/000188 WO2001053524A2 (en) 2000-01-18 2001-01-18 Cancer associated genes and their products

Publications (1)

Publication Number Publication Date
AU2001226922A1 true AU2001226922A1 (en) 2001-07-31

Family

ID=9883810

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001226922A Abandoned AU2001226922A1 (en) 2000-01-18 2001-01-18 Cancer associated genes and their products

Country Status (6)

Country Link
US (1) US20030180738A1 (en)
EP (1) EP1250457A2 (en)
AU (1) AU2001226922A1 (en)
CA (1) CA2397910A1 (en)
GB (1) GB0000993D0 (en)
WO (1) WO2001053524A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080050836A1 (en) * 1998-05-01 2008-02-28 Isabelle Guyon Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
US20090226915A1 (en) 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
US7414032B2 (en) 2001-06-25 2008-08-19 Immunofrontier, Inc. Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8+ CTL
US8008012B2 (en) 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
GB0218468D0 (en) * 2002-08-08 2002-09-18 Univ Nottingham Trent Gastric and Colon Cancer-associated antigens
WO2004016790A1 (en) 2002-08-14 2004-02-26 National Institute Of Advanced Industrial Science And Technology Novel n-acetylgalactosamine transferases and nucleic acids encoding the same
WO2005078124A2 (en) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostic marker for cancer
DE102004038076A1 (en) * 2004-02-16 2005-09-01 Proteosys Ag Use of annexin A3, or other proteins, as diagnostic markers for cancer, especially of the prostate, also use of modulators of these markers for treating cancer
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004265A2 (en) * 1997-07-17 1999-01-28 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides

Also Published As

Publication number Publication date
EP1250457A2 (en) 2002-10-23
GB0000993D0 (en) 2000-03-08
WO2001053524A3 (en) 2002-03-14
CA2397910A1 (en) 2001-07-26
WO2001053524A2 (en) 2001-07-26
US20030180738A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AU2001285047A1 (en) Human genes and gene expression products
AU2001245619A1 (en) Human genes and gene expression products
AU6069300A (en) Novel human genes and gene expression products
AU4053699A (en) Novel human genes and gene expression products
AU2001257453A1 (en) Product feature and relation comparison system
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AU4187499A (en) Human genes and gene expression products v
AU2001247246A1 (en) Product return system and methods
AU2002219107A1 (en) Antiperspirant products
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU1922301A (en) Differential gene expression in cancer
AU2088801A (en) Metastasis genes and uses thereof
AU2002327607A1 (en) Human genes and gene expression products isolated from human prostate
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2001226922A1 (en) Cancer associated genes and their products
AU2001240103A1 (en) Reproduction-specific genes
GB9828840D0 (en) Prostate cancer associated genes and their products
AU2376200A (en) Insulin-synthesis genes
AU2001287269A1 (en) Human genes and expression products
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU6263999A (en) Human genes and gene expression products
AU2002217984A1 (en) Erythropoietin and erythropoietin receptor expression in human cancer
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy